CLINICAL QUESTIONS, WIDER SYSTEMS.

Research

al populations. Prescribing behaviour therefore becomes part of microbial ecology, and antimicrobial stewardship becomes not simply a matter of reducing drug use but of understanding the biological consequences of that use.

This perspective has increasingly shaped the way I think about infection and resistance: less as a sequence of individual events and more as a dynamic system.

Selected themes:
AMR · MRSA · ESBL · NDM-1 · Carbapenem Resistance · Antimicrobial Stewardship

Infection, Colonisation and Transmission

Clinical infection is rarely explained by a single organism or a single route of transmission.

My work has included the epidemiology of healthcare-associated infection, screening and colonisation, infection prevention and the investigation of possible transmission within healthcare settings.

These questions repeatedly expose an important distinction: the presence of an organism does not automatically establish disease, and similarity between isolates does not by itself establish transmission.

Understanding infection therefore requires bringing together microbiology, clinical context, epidemiology, patient movement, antimicrobial exposure and the healthcare environment.
This has led me to favour explanations that account for the whole system rather than attributing infection too readily to an individual event or institutional failure.

Selected themes:
Healthcare-Associated Infection · Infection Prevention · Colonisation · Screening · Transmission · Epidemiology

Diagnostics and the Meaning of a Result

One recurring lesson of laboratory medicine is that detection and meaning are not the same thing.

A laboratory test can be technically accurate and yet still be misunderstood clinically. The significance of a positive result depends on prevalence, symptoms, timing, persistence, colonisation, prior treatment and the purpose for which the test was performed.

These problems became particularly visible during the COVID-19 pandemic, but they are not unique to COVID-19. They are fundamental to diagnostic medicine.
This has developed into a continuing interest in diagnostic interpretation, uncertainty and the relationship between laboratory categories and the people to whom those categories are applied.

A test result is evidence. It is not, by itself, a complete clinical judgement.

Selected themes:
Diagnostic Interpretation · Clinical Microbiology · Screening · Laboratory Evidence · Uncertainty · Detection versus Disease

Genomic Epidemiology

Genomic methods offer extraordinary resolution for studying microorganisms and possible transmission.

My recent work has included using genomic epidemiology in investigate Clostridioides difficile infection. Whole-genome approaches can reveal relationships that conventional typing cannot, but they can also challenge assumptions about apparent outbreaks.

This is particularly interesting when genomic evidence suggests that cases occurring in the same hospital and within similar periods are not necessarily linked by recent transmission.
Genomics therefore does more than increase technical precision. It can change the causal story.

That has reinforced my broader interest in distinguishing between what is observed, what is inferred and what the evidence is actually capable of proving.

Selected themes:
Genomic Epidemiology · Whole-Genome Sequencing · C. difficile · Transmission Analysis · Molecular Epidemiology

Microbial Ecology and Antibiotic Pressure

Increasingly, I have become interested in infection as an ecological problem.

Antibiotics do not act only on the organism being treated. They alter microbial communities, change competitive relationships and create selective environments in which some organisms flourish while others disappear.

This perspective is especially relevant to conditions such as C. difficile infection, where disruption of the normal intestinal microbiota is central to disease.
It also raises a wider question: how much of what we describe as an “infection-control problem” is actually the downstream consequence of antimicrobial ecology?

The answer will differ between organisms and settings, but the question matters. It shifts attention from the immediate event to the conditions that made it possible.

Selected themes:
Microbial Ecology · Antibiotic Pressure · Dysbiosis · C. difficile · Ecological Selection · Antimicrobial Exposure

Systems Thinking in Clinical Microbiology

My research interests have gradually moved from individual organisms towards the systems in which organisms, patients, clinicians, laboratories and institutions interact.

Infection is biological, but it is also organisational.

A laboratory result influences a clinician. A clinician changes treatment. Treatment alters microbial ecology. Infection-control policies change behaviour. Screening creates categories. Administrative systems then act on those categories.

Each step may be reasonable in isolation, but can produce unexpected consequences when combined.

This systems perspective has increasingly influenced both my research and my wider writing. I am interested not only in whether an intervention works, but also in the assumptions behind it, the secondary effects it creates, and how evidence moves from laboratory observation to institutional policy.

Publications and Research Profiles

My scientific work has been published principally under Jayanta B. Sarma and J. B. Sarma.

For a fuller publication record:
Google Scholar
Citation record and indexed publications.
ORCID
Persistent researcher identity and publication record.
ResearchGate
Publications, conference presentations, posters and other research material.
PubMed
Biomedical publications indexed in the medical literature.

elected Work

Rather than reproduce a complete bibliography here, I plan to highlight a small number of papers and projects that represent different stages of my research interests:

antimicrobial resistance and MRSA;
extended-spectrum beta-lactamase-producing organisms;
NDM-1 and carbapenem resistance;
healthcare-associated infection and screening;
antimicrobial stewardship;
genomic epidemiology of Clostridioides difficile;
diagnostic interpretation and the relationship between laboratory evidence and clinical meaning.

A complete publication record is available through the research profiles above.